Trial intelligence / Profile preview

DOSER: 150 mg Clopidogrel for High Platelet Reactivity after PCI

NCT00638326Phase 3Terminated

Sponsor
University of Pécs
Start
Mar 2008
Primary completion
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of clopidogrel in stable angina pectoris, sponsored by University of Pécs. Started Mar 2008; status: terminated.

02

Drugs

clopidogrel
03

Conditions

stable angina pectoris

Beyond the preview

Go deeper on NCT00638326.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00638326.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call